Company profile: Response Biomedical
1.1 - Company Overview
Company description
- Provider of rapid on-site diagnostic tests for the RAMP Platform, including RAMP NT-proBNP for congestive heart failure, Troponin I for acute myocardial infarction, D-dimer to help rule out venous thromboembolism, Procalcitonin to distinguish bacterial sepsis, and COVID-19 antigen and Flu A+B tests, delivering results in about 15 minutes.
Products and services
- RAMP Troponin I Test: A RAMP Platform-based assay that aids accurate diagnosis of acute myocardial infarction, delivering lab-quality results quickly for urgent cardiac evaluation
- RAMP D-dimer Test: An EDTA whole blood-based RAMP assay that measures D-dimer to help rule out venous thromboembolism, producing results in about 15 minutes
- RAMP NT-proBNP Test: A rapid on-site RAMP assay for diagnosis and assessment of congestive heart failure, producing results in about 15 minutes
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Response Biomedical
Elitech
HQ: France
Website
- Description: Provider of in vitro diagnostic equipment, reagents, and software for clinical and research laboratories, offering molecular diagnostics, clinical chemistry benchtop analyzers, microbiology solutions, and biomedical systems. Portfolio includes Selectra Mach5 and Selectra Pro & Mach5 systems with ready-to-use reagents, calibrators, controls, and consumables.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Elitech company profile →
Zevacor
HQ: United States
Website
- Description: Provider of PET and SPECT radiopharmaceuticals, developing, manufacturing, and distributing compounds for PET and SPECT imaging to aid in the diagnosis, monitoring, and management of medical conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zevacor company profile →
RTA Labs
HQ: Turkey
Website
- Description: Provider of medical and industrial biotechnology products, offering media in Petri, tube, and bottle; quick tests; chromogenic media; blood culture bottles; painting sets; hygislide; tuberculosis diagnosis; and sure check media, supported by an R&D laboratory suitable for molecular biology-genetics and immunology-serology-based studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RTA Labs company profile →
Oxford Biosystems
HQ: United Kingdom
Website
- Description: Provider of diagnostic and research reagents and instrumentation to laboratories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oxford Biosystems company profile →
Securetec
HQ: Germany
Website
- Description: Provider of leading-edge detection technologies for drugs, explosives, and hazardous substances, employed across a multitude of applications. In-house development and production ensure products meet the highest clinical standards.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Securetec company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Response Biomedical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Response Biomedical
2.2 - Growth funds investing in similar companies to Response Biomedical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Response Biomedical
4.2 - Public trading comparable groups for Response Biomedical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →